
Pharma industry hopes for relief from GST reforms
The Hindu
Pharma industry optimistic about GST reforms addressing concerns, improving affordability, accessibility, and global competitiveness of Indian pharmaceuticals.
More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












